Back To Search Instructions
Protocols
10 protocols meet the specified criteria
Disease Site: Cervix Uteri
Protocol No.TitleStatus
1606636273A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal CancerOpen
1704390293A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab anti-PD-1 Monoclonal Antibody) and in Combination with Both Nivolumab and Ipilimumab (anti-CTLA-4 Monoclonal Antibody) in Advanced Malignant TumorsOpen
PHXA-16-0094-80-15PHASE 3 STUDY OF ADXS11-001 ADMINISTERED FOLLOWING CHEMORADIATION AS ADJUVANT TREATMENT FOR HIGH RISK LOCALLY ADVANCED CERVICAL CANCER:AIM2CERV Open
PHXB-11OB053Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical HysterectomyClosed
PHXB-11OB103A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: THE OUTBACK TRIAL (ANZGOG 0902)Closed
PHXB-15-0004-10-15Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy with Pelvic Lympadenectomy) for Stage 1A1 (LVSI+) and IA2-IB1 (¡Ü 2CM) Cervical CancerClosed
PHXB-15-0018-10-15Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic LymphadenectomyClosed
PHXB-15-0027-70-15Analyzing Vaginal Microbiomes in Gynecological Oncology PatientsClosed
PHXB-17-0120-10-15Prospective Comparative Effectiveness Trial for Malignant Bowel ObstructionOpen
PHXE-17-0216-10-15EAY131: Molecular Analysis for Therapy Choice (MATCH) Open